Neurocrine Biosciences, Inc.NBIXNASDAQ
Loading
Operating Margin Over TimeContracting
Percentile Rank85
3Y CAGR+9.0%
5Y CAGR+6.8%
Year-over-Year Change
Operating income as a percentage of revenue
3Y CAGR
+9.0%/yr
vs +19.7%/yr prior
5Y CAGR
+6.8%/yr
Consistent
Acceleration
-10.7pp
Decelerating
Percentile
P85
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | 21.64% | -10.6% |
| 2024 | 24.22% | +82.2% |
| 2023 | 13.30% | -20.5% |
| 2022 | 16.73% | +85.0% |
| 2021 | 9.04% | -42.0% |
| 2020 | 15.58% | +69.9% |
| 2019 | 9.17% | +12.5% |
| 2018 | 8.16% | +110.0% |
| 2017 | -81.27% | +91.7% |
| 2016 | -982.48% | - |